Clinical Trials
7 trialsNCT05155189 2026-01-21
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
Zhejiang University
Phase 1 Recruiting
NCT05803928 2024-07-24
Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies
Third Affiliated Hospital, Sun Yat-Sen University
Phase 1 Recruiting
NCT03418922 2024-06-20
A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma
Eisai Inc.
Phase 1 Completed
NCT05533892 2023-12-19
CCGLC-007
Tongji Hospital
Phase 1 Unknown
NCT03006926 2023-12-13
A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma
Eisai Inc.
Phase 1 Completed
NCT05675462 2023-03-06
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
Fudan University
Phase 1 Unknown
NCT05225116 2023-02-08
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
Beijing Tsinghua Chang Gung Hospital
Phase 1 Unknown